Genoox is a healthcare and technology company aiming to make clinical genetic sequencing more accessible. Using the company's cloud-based advanced framework encompassing purpose-built applications, users can easily manage the entire genetic sequencing process and create virtual genetic test modules providing plug-and-play options for the delivery of clinical actionable insights and disease diagnoses. Driven by artificial-intelligence technology, the company's product, Franklin, integrates data from published literature and publicly available population, disease, and sequence databases and employs machine learning to derive a prediction aggregation score and adjust the weights of ACMG classification criteria. Genoox aims to improve patient outcomes with increased accuracy and efficiency, enabling personalized medicine and patient-specific treatments.